RealFeedApp Biotech IPOs jumped 573% in 2026
The iShares Biotechnology ETF (IBB) surged 34% to $207.74, while the State Street SPDR S&P Biotech ETF (XBI) jumped 39% to $149.54. Nine IPOs totaling $2.4 billion reached Wall Street in Q3 2026, the largest number in five years.
- Field
- business and funding
- What they did
- Investment bank Locust Walk reported a record recovery in the biotech sector in 2026, with funds rising 34–39% and IPOs increasing 5.7 times compared to the previous year.
- Why it matters
- This growth is interesting to investors as it shows the biotech market has recovered from the post-pandemic slump and is ready for new company listings.
#biotech stocks#ipo#investment bank#etf#market recovery
